Sonoma Pharmaceuticals, Inc. (SNOA): Price and Financial Metrics

SNOA POWR Grades

• Value is the dimension where SNOA ranks best; there it ranks ahead of 68.35% of US stocks.
• The strongest trend for SNOA is in Momentum, which has been heading down over the past 33 weeks.
• SNOA ranks lowest in Stability; there it ranks in the 7th percentile.

SNOA Stock Summary

• SNOA has a market capitalization of $11,110,602 -- more than approximately only 0.1% of US stocks.
• Sonoma Pharmaceuticals Inc's capital turnover -- a measure of revenue relative to shareholder's equity -- is better than 87.64% of US listed stocks.
• As for revenue growth, note that SNOA's revenue has grown -17.24% over the past 12 months; that beats the revenue growth of merely 13.34% of US companies in our set.
• Stocks with similar financial metrics, market capitalization, and price volatility to Sonoma Pharmaceuticals Inc are EIG, PSMT, FHI, EVI, and DORM.
• Visit SNOA's SEC page to see the company's official filings. To visit the company's web site, go to www.sonomapharma.com.

SNOA Valuation Summary

• In comparison to the median Healthcare stock, SNOA's price/sales ratio is 78.95% lower, now standing at 0.8.
• SNOA's price/sales ratio has moved down 20.2 over the prior 177 months.
• Over the past 177 months, SNOA's EV/EBIT ratio has gone up 2.

Below are key valuation metrics over time for SNOA.

SNOA Growth Metrics

• The 4 year net cashflow from operations growth rate now stands at 47.51%.
• Its 3 year cash and equivalents growth rate is now at -50.61%.
• Its 5 year net cashflow from operations growth rate is now at 42.74%.

Over the past 52 months, SNOA's revenue has gone up $3,721,000.

The table below shows SNOA's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2021-06-30	16.546	-2.31	-5.288
2021-03-31	18.629	-3.378	-3.95
2020-12-31	21.051	-5.493	-1.664
2020-09-30	20.793	-7.079	-2.098
2020-06-30	19.992	-7.62	-3.421
2020-06-30	21.479	-7.611	-2.668

SNOA's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• SNOA has a Quality Grade of D, ranking ahead of 20.88% of graded US stocks.
• SNOA's asset turnover comes in at 1.011 -- ranking 23rd of 677 Pharmaceutical Products stocks.
• HALO, NAVB, and MNKD are the stocks whose asset turnover ratios are most correlated with SNOA.

The table below shows SNOA's key quality metrics over time.